Among inflammatory-lipid indices, CTI showed the most consistent associations and provided the largest numerical incremental discrimination beyond Lp(a) and CTI level, and may complement Lp(a) by capturing inflammatory-metabolic status for more refined characterization of lesion-burden risk in ACS.
Abstract
Lipoprotein(a) [Lp(a)] reflects inherited atherothrombotic risk, whereas the C-reactive protein-triglyceride-glucose index (CTI) integrates systemic inflammation, triglyceride-related lipid disturbance, and glucose-related metabolic stress. Their individual and joint association with angiographic coronary lesion burden in acute coronary syndrome (ACS) remain incompletely defined. We examined whether CTI complements Lp(a) in characterizing coronary lesion burden in ACS. This retrospective, single-center study included 2,836 consecutive patients with ACS who underwent coronary angiography. Coronary lesion burden was assessed using continuous Gensini score, a high Gensini score, and multivessel disease (MVD). Multivariable regression, restricted cubic spline analyses, CTI-stratified analyses, incremental receiver operating characteristic analyses, and internally validated machine-learning analyses with SHAP interpretation were performed. Higher Lp(a) and CTI level were both associated with greater coronary lesion burden. Compared with Lp(a) < 75 nmol/L, Lp(a) ≥175 nmol/L was associated with high Gensini score (OR, 1.51 [95% CI, 1.17–1.96]) and MVD (OR, 1.69 [95% CI, 1.27–2.26]). Each 1-SD increase in CTI was associated with high Gensini score (OR, 1.47 [95% CI, 1.35–1.60]) and MVD (OR, 1.18 [95% CI, 1.08–1.28]). Among inflammatory-lipid indices, CTI showed the most consistent associations and provided the largest numerical incremental discrimination beyond Lp(a). The association between very high Lp(a) and coronary lesion burden was more pronounced at higher CTI levels, particularly for MVD. Machine-learning analyses further supported the relevance of both CTI and Lp(a). In patients with ACS, higher Lp(a) and CTI levels were associated with greater angiographic coronary lesion burden. CTI may complement Lp(a) by capturing inflammatory-metabolic status, supporting their joint assessment for more refined characterization of lesion-burden risk in ACS.
A higher CHG index was associated with a higher Gensini score in patients with CAD, suggesting that this simple and inexpensive metabolic marker may provide complementary information for assessing coronary atherosclerotic burden.
Jia-Yu Zhang, Hong-Xin Dong, Sheng Lei et al.· Frontiers in Nutrition· 0 citations
In patients with CAD, elevated CTI and MSCAC independently portend adverse outcomes, and their coexistence identifies a particularly high‑risk phenotype, which supports the complementary value of metabolic‑inflammatory and anatomic measures in risk stratification.
Song Wen, Zhan-Yuan Chen, Rui Fu et al.· Coronary Artery Disease· 0 citations
Objective This study sought to explore the relationship between the C-reactive protein-triglyceride-glucose index (CTI) and the incidence of myocardial ischemia in patients with minimal to moderate coronary artery disease (CAD). Methods The research retrospectively included 707 patients who underwent coronary computed...
Zeng-Fa Huang, Beibei Cao, Xiao-Yu Liu et al.· Frontiers in Medicine· 0 citations
CTI is an independently associated factor for coronary stenosis severity in patients with hypertension, particularly in those with H-type hypertension and comorbid diabetes, and holds promise as a practical tool for early risk stratification and for guiding individualized prevention strategies.
Li Luo, Lian Wang, Xiang-Bing Yu et al.· Cardiovascular Diabetology· 0 citations
Background Metabolic dysfunction, including insulin resistance, inflammation, and dyslipidaemia, plays a critical role in the development of coronary artery disease (CAD). The triglyceride-glucose (TyG) index, the C-reactive protein-triglyceride-glucose index (CTI), and the atherogenic index of plasma (AIP) are accessi...
Run-Zhe Wu, Cong-Ying Wang, Lu-Lu Pan et al.· Frontiers in Nutrition· 0 citations
It is suggested that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population of patients with chronic coronary syndrome after percutaneous coronary intervention (PCI).
Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al.· Biomarkers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.